Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Ehrenstein

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
The Journal of Experimental Medicine|September 26, 2007
If the treatment works, do we need to know why?: the promise of immunotherapy for experimental medicineMichael R Ehrenstein, Claudia Mauri
The Journal of Experimental Medicine|April 25, 2023
SLE is not a one-size-fits-all diseaseMichael R Ehrenstein, Muhammad Shipa
Arthritis Research & Therapy|March 14, 2007
Cells of the synovium in rheumatoid arthritis. B cellsClaudia Mauri, Michael R Ehrenstein
Trends in Immunology|February 22, 2008
The 'short' history of regulatory B cellsClaudia Mauri, Michael R Ehrenstein
Nature Reviews. Rheumatology|February 19, 2016
The BAFFling effects of rituximab in lupus: danger ahead?Michael R Ehrenstein, Charlotte Wing
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2002
Cutting edge: selection of B lymphocyte subsets is regulated by natural IgMNicole Baker, Michael R Ehrenstein
FEBS Letters|August 11, 2011
Regulatory T-cells in systemic lupus erythematosus and rheumatoid arthritisKonstantia-Maria Chavele, Michael R Ehrenstein
The Journal of Experimental Medicine|June 9, 2016
Anti-TNF drives regulatory T cell expansion by paradoxically promoting membrane TNF-TNF-RII binding in rheumatoid arthritisDao Xuan Nguyen, Michael R Ehrenstein
Nature Reviews. Immunology|October 16, 2010
The importance of natural IgM: scavenger, protector and regulatorMichael R Ehrenstein, Clare A Notley
Rheumatology (Oxford, England)|February 11, 2015
The impact of biological therapy on regulatory T cells in rheumatoid arthritisRachel Byng-Maddick, Michael R Ehrenstein
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
The Journal of Experimental Medicine|September 26, 2007
If the treatment works, do we need to know why?: the promise of immunotherapy for experimental medicineMichael R Ehrenstein, Claudia Mauri
The Journal of Experimental Medicine|April 25, 2023
SLE is not a one-size-fits-all diseaseMichael R Ehrenstein, Muhammad Shipa
Arthritis Research & Therapy|March 14, 2007
Cells of the synovium in rheumatoid arthritis. B cellsClaudia Mauri, Michael R Ehrenstein
Trends in Immunology|February 22, 2008
The 'short' history of regulatory B cellsClaudia Mauri, Michael R Ehrenstein
Nature Reviews. Rheumatology|February 19, 2016
The BAFFling effects of rituximab in lupus: danger ahead?Michael R Ehrenstein, Charlotte Wing
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2002
Cutting edge: selection of B lymphocyte subsets is regulated by natural IgMNicole Baker, Michael R Ehrenstein
FEBS Letters|August 11, 2011
Regulatory T-cells in systemic lupus erythematosus and rheumatoid arthritisKonstantia-Maria Chavele, Michael R Ehrenstein
The Journal of Experimental Medicine|June 9, 2016
Anti-TNF drives regulatory T cell expansion by paradoxically promoting membrane TNF-TNF-RII binding in rheumatoid arthritisDao Xuan Nguyen, Michael R Ehrenstein
Nature Reviews. Immunology|October 16, 2010
The importance of natural IgM: scavenger, protector and regulatorMichael R Ehrenstein, Clare A Notley
Rheumatology (Oxford, England)|February 11, 2015
The impact of biological therapy on regulatory T cells in rheumatoid arthritisRachel Byng-Maddick, Michael R Ehrenstein
Pageof 7